Review of the Effect of Ethyl Methane Sulphonate

(EMS) on Medicinal Plants

(1)
Dr. Manju Soni, (2) Mrs. Mayuri Gaurav Tatte
(1)
Guide & Assistant Professor, (2) Research Scholar & Assistant Professor
(1)
Priyadarshi College Of Engineering, Hingana, Nagpur.
(2)
Shri Shivaj Science College, Nagpur.

ABSTRACT

Ethyl methane sulphonate (EMS) is a widely used mutagenic agent in plant breeding
programs to induce genetic variability. In this review paper, we explore the effects of EMS on
various medicinal plants. The primary objective is to understand the extent to which EMS
treatment influences the morphological, physiological, biochemical, and molecular
characteristics of these plants. Through a comprehensive examination of existing literature,
this review provides insights into the potential applications of EMS in enhancing the
medicinal properties of plants and facilitating the development of novel cultivars with
improved traits. Additionally, we discuss the challenges associated with EMS mutagenesis
and propose future research directions to maximize its benefits in medicinal plant breeding.

Keywords: Ethyl Methane Sulphonate, EMS, Medicinal Plants, Mutagenesis, Genetic

Variability, Plant Breeding

INTRODUCTION

Ethyl Methane Sulphonate (EMS) is a widely used mutagen in plant breeding, offering a
versatile tool for inducing genetic variability. Its application in medicinal plants presents a
promising avenue for enhancing their beneficial properties, particularly in the context of the
growing demand for natural remedies and pharmaceutical ingredients. Medicinal plants have
been integral to human civilization for millennia, serving as sources of traditional remedies
and modern pharmaceuticals. However, their wild counterparts often exhibit limited genetic
variation, making it crucial to augment their genetic diversity through targeted breeding
strategies. EMS can induce mutations within the plant genome, generating novel genetic
variants with altered phenotypic characteristics. By selectively screening and breeding these
mutants, breeders can potentially unlock desirable traits such as enhanced medicinal potency,
increased biomass yield, or improved tolerance to biotic and abiotic stresses. This review
provides a comprehensive overview of the effects of EMS on medicinal plants, encompassing
its mutagenic potential, implications for genetic diversity generation, alteration of medicinal
properties, and consequences for yield and growth characteristics. It emphasizes the
importance of responsible and ethical utilization of EMS-mediated mutagenesis in fostering
agricultural sustainability and advancing global healthcare initiatives.
Medicinal plants have long been valued for their therapeutic properties, and understanding
their genetic makeup and variability is crucial for their sustainable use and enhancement.
Mutagenesis, the induction of genetic variability through chemical agents, is a promising tool
for breeding and improving medicinal plants. Ethyl Methane Sulphonate (EMS), a widely
used chemical mutagen, has been shown to induce point mutations in various organisms,
including medicinal plants. This alters the genetic composition, potentially leading to the
development of novel strains with enhanced therapeutic properties. However, the use of EMS
raises important considerations and warrants a comprehensive review. This review critically
evaluates the effects of EMS on medicinal plants, examining its impact on genetic diversity,
phenotypic traits, and biochemical composition. It synthesizes existing literature and
empirical evidence to provide insights into the potential benefits and limitations of EMS-
induced mutagenesis in medicinal plant research and breeding programs.
This review explores the impact of EMS on medicinal plants, focusing on the types and
frequencies of mutations induced by EMS and their implications for genetic variability. It
also examines the phenotypic consequences of EMS mutagenesis, identifying morphological,
physiological, and developmental changes in plants. The review also examines the
biochemical profile of medicinal plants after EMS treatment, providing insights into potential
changes in secondary metabolites responsible for their therapeutic properties. The review
aims to inform future research directions and practical applications for harnessing genetic
variability for the sustainable advancement of medicinal plant resources. It contributes to the
ongoing dialogue surrounding the use of mutagenesis as a tool for enhancing the therapeutic
potential of medicinal plants.

Ethyl Methane Sulphonate (EMS) as a Mutagenic Agent

Ethyl Methane Sulphonate (EMS) is a potent mutagenic agent in plant breeding, enabling the
induction of genetic variations for medicinal plant improvement. Its mechanism involves
alkylating guanine residues within DNA, leading to ethylated guanine adducts, which can
result in base pair substitutions during DNA replication. These substitutions, known as point
mutations, alter the genetic code and can cause DNA strand breaks, deletions, or insertions,
further contributing to genomic variability. EMS mutagenic potency is influenced by factors
such as concentration, exposure duration, and environmental conditions. Higher
concentrations and prolonged exposure times generally yield a greater frequency of mutations
but with an increased risk of detrimental changes or lethality. Therefore, careful optimization
of EMS dosage and treatment protocols is crucial to balance mutagenesis efficiency and plant
viability. Despite its stochastic nature, EMS enables breeders to introduce genetic variability
into medicinal plant populations, identifying individuals with desirable traits like enhanced
medicinal potency or improved agronomic characteristics. These mutants serve as valuable
genetic resources for breeding efforts to develop commercially viable cultivars. EMS's
mutagenic potential allows breeders to navigate the complexities of medicinal plant
improvement with precision and efficacy, contributing to healthcare and agriculture
advancements.

HISTORY OF MUTAGENESIS

1885: Hugo de Vries proposed the theory of mutationism, suggesting that new species arise

from sudden, heritable changes (mutations) rather than gradual evolution. Though not

directly related to induced mutagenesis, it laid the conceptual groundwork for understanding

genetic variation.

1927-1928: Hermann Muller conducted experiments exposing fruit flies (Drosophila

melanogaster) to X-rays. He demonstrated that X-rays can induce mutations, leading to

changes in eye colour and other visible traits. This work earned him the Nobel Prize in

Physiology or Medicine in 1946.

1940s: Charlotte Auerbach and J.M. Robson conducted experiments demonstrating the

mutagenic effects of mustard gas (a chemical warfare agent) on fruit flies and bacteria. This

research provided evidence for the mutagenic potential of chemical substances.

1946: Hermann Muller was awarded the Nobel Prize in Physiology or Medicine for his

discoveries concerning the production of mutations by X-ray irradiation.

1940s-1950s: The development of chemical mutagens continued with the discovery of other

compounds, such as nitrogen mustard and ethyl methane sulfonate (EMS), which could

induce mutations in organisms. These discoveries expanded the toolkit for researchers

studying mutagenesis.

1950s: The discovery of DNA's structure and the elucidation of its role as the carrier of

genetic information provided a molecular basis for understanding how mutations occur and

are inherited.
1953: James Watson and Francis Crick proposed the double helix structure of DNA,

providing insight into how mutations might alter this structure and affect inheritance.

1960s-1970s: Advances in molecular biology and genetics led to the development of more

sophisticated techniques for studying mutagenesis, including methods for detecting and

analyzing mutations at the molecular level.

1970s-1980s: The use of mutagenesis in crop improvement gained momentum, with

researchers employing radiation and chemical mutagens to generate genetic variability for

breeding programs aimed at developing new crop varieties with desirable traits.

1980s-present: Continued advancements in molecular biology, including the development of

techniques such as polymerase chain reaction (PCR) and genome sequencing, have facilitated

the study of mutagenesis at the molecular level. This has led to a deeper understanding of the

mechanisms underlying mutation induction and DNA repair processes.

2000s-present: The advent of genome editing technologies, such as CRISPR-Cas9, has

revolutionized the field of mutagenesis, allowing for precise and targeted modifications of

DNA sequences. These tools offer unprecedented control over genetic manipulation and hold

promise for applications in research, medicine, and agriculture.

IMPORTANCE OF MEDICINAL PLANTS

1. Traditional Medicine: Medicinal plants have been integral to traditional healing practices
across cultures for centuries, serving as primary sources of remedies for various ailments.

2. Pharmaceutical Industry: Many modern pharmaceutical drugs are derived from

compounds found in medicinal plants, highlighting their significance in drug discovery and
development.

3. Global Health: Medicinal plants play a crucial role in addressing global health challenges
by providing accessible and affordable treatments for a wide range of diseases, especially in
regions with limited access to modern healthcare facilities.
4. Biodiversity Conservation: Medicinal plants contribute to the conservation of
biodiversity by serving as habitats and food sources for diverse ecosystems, emphasizing the
need for their sustainable management and preservation.

5. Economic Value: The cultivation, processing, and trade of medicinal plants form a
significant component of the global economy, providing livelihoods for millions of people
involved in the herbal medicine industry.

6. Cultural Heritage: Many medicinal plants hold cultural and spiritual significance,
forming an essential part of traditional knowledge systems and indigenous practices passed
down through generations.

7. Environmental Benefits: Medicinal plants contribute to ecosystem services such as soil

stabilization, carbon sequestration, and water purification, making them crucial for
environmental sustainability and ecosystem resilience.

8. Nutritional Support: Some medicinal plants also serve as nutritional supplements,

providing essential vitamins, minerals, and phytonutrients that contribute to overall health
and well-being.

LITERATURE REVIEW
Puente (2020) This study aimed to induce morphological mutants in C. indicum var. var.
aromaticum using ethyl methanesulfonate (EMS) treatments with different doses. Results
showed significant effects of EMS doses on seed germination, with the sample germination
rate decreasing with increasing doses. The resulting morphological mutants were two viable
types, containing leaf and stem mutants. Leaf size and height increased, while anatomical
characteristics showed changes in leaves and stems. The puncture strength of bent stems was
low, and the total lignin and cellulose contents of mutant plant stems decreased significantly.
This method shows the efficiency of EMS in causing mutations in plants.

A. Junaid (2008) A four-step protocol for in vitro propagation of Dracaena sanderiana

Sander ex Mast was developed. Callus initiation, regeneration, shoot elongation, and rooting
were achieved from nodal stem segment explants treated with varying concentrations of
ethylmethane sulphonate (EMS) on MS medium supplemented with 2,4-
dichlorophenoxyacetic acid. Lower EMS-treated lines showed increased callus induction
percentage and biomass production. Calli of the ET1 line showed high regeneration potential.

Lavanya (2022) The study aims to explore the use of mutation breeding in vegetatively
propagated crops like Jasminum auriculatum to create desirable variation. The optimum dose
of mutagen maximizes mutation frequency while minimizing killing. The study analyzes the
Lethal Dose (LD50) and growth reduction dose (GR50) for Gamma irradiation (GI) and
Ethyl methane sulphonate (EMS) treatments on the ecotype 'Muthu Mullai' of Jasminum
auriculatum. The LD50 values ranged from 12.479 Gy for GI and 13.268 mM for EMS
treatment. The mutagenic efficiency and effectiveness were found to be 214.96 and 89.36 for
GI and 48.66 and 33.77 for EMS treatment, respectively. These doses can be used in future
crop improvement programs for Jasmine.

Kumar (2021) The study aimed to create salt-tolerant Artemisia vulgaris L. through in vitro
mutagenesis using ethyl methane sulphonate (EMS) as a chemical mutagen. NaCl tolerance
was assessed by maintaining callus growth under different concentrations. The study found
that NaCl concentrations at 500 mM did not show any callus development, so biochemical
and antioxidant assays were limited to 0–400 mM NaCl. However, calluses treated with 0.5%
EMS for 30-60 minutes and subcultured on basal media fortified with different
concentrations of 0–400 mM NaCl were found to induce mutations. The mutants showed
enhanced tolerance to NaCl stress, indicating increased biochemical and antioxidant activity.

Lenawaty (2022) The study explores the use of Ethyl Methane Sulfonate (EMS) in
increasing the diversity of marigolds (Tagetes sp.) through chemical induction mutations. The
researchers used genetic material from T. erecta genotype MG04 and T. patula genotype
MG21. The acute mutation technique involved soaking seeds in EMS concentration for 4
hours under various concentration levels. The chronic mutation technique involved diluting
the concentration of EMS and immersing the seeds for various periods. The results showed
that T. erecta had a higher sensitivity level to EMS treatment than T. patula. The acute
application method showed a low mutation rate and limited flower diversity. The chronic
application method produced various flower shapes and whiter colours, resulting in a redder
flower colour.

TYPES OF MUTAGENS

Mutagens are agents that induce mutations in the genetic material of organisms. They can be
classified into two main categories based on their nature: chemical mutagens and physical
mutagens.

Chemical Mutagens Physical Mutagens

Alkylating Agents Ionizing Radiation
Base Analogs Ultraviolet (UV) Radiation
 Intercalating Agents Heat
Deaminating Agents Mechanical Stress
Crosslinking Agents

A. Chemical Mutagens

1. Alkylating Agents: These chemicals add alkyl groups to DNA bases, disrupting base
pairing and causing point mutations. Examples include ethyl methane sulfonate (EMS) and
ethyl methanesulfonate (EMS).

2. Base Analogs: Chemicals that resemble DNA bases can be incorporated into the DNA
during replication, leading to mismatches and mutations. For example, 5-bromouracil
resembles thymine and can pair with adenine or guanine.

3. Intercalating Agents: These molecules insert themselves between the DNA base pairs,
causing frameshift mutations by distorting the DNA structure. Examples include ethidium
bromide and acridine orange.

4. Deaminating Agents: Chemicals that remove amino groups from DNA bases, leading to
base substitutions. Nitrous acid is an example of a deaminating agent.

5. Crosslinking Agents: These chemicals form covalent bonds between DNA strands or
between DNA and proteins, causing DNA damage and mutations. Psoralens and mitomycin C
are examples of crosslinking agents.

B. Physical Mutagens

1. Ionizing Radiation: Radiation with sufficient energy to ionize atoms and molecules can
cause DNA damage by directly breaking the DNA strands or generating reactive oxygen
species. Examples include X-rays, gamma rays, and cosmic rays.

2. Ultraviolet (UV) Radiation: UV radiation induces mutations by forming thymine dimers,

covalent bonds between adjacent thymine bases in the DNA strand. UV light is categorized
into UVA, UVB, and UVC, with shorter wavelengths causing more damage.

3. Heat: High temperatures can cause DNA strand breaks, denature proteins involved in
DNA replication and repair, and increase the rate of mutations.

4. Mechanical Stress: Physical forces such as shear stress or pressure can cause DNA
damage, including strand breaks and chromosomal rearrangements.
Both chemical and physical mutagens have various applications in scientific research,
agriculture, medicine, and industry. Understanding their mechanisms of action and effects on
DNA helps researchers manipulate genetic material for beneficial purposes, such as crop
improvement, disease treatment, and genetic engineering. However, it is essential to consider
the potential risks associated with mutagen exposure, including carcinogenesis and heritable
genetic disorders.

EXAMPLES OF CHEMICAL MUTAGEN

Chemical mutagens are substances that can induce mutations in the genetic material of
organisms. Here are some examples of chemical mutagens along with their mechanisms of
action:

Ethyl Methane Sulfonate (EMS):

EMS is an alkylating agent that adds ethyl groups to DNA bases, particularly guanine. It
induces point mutations by causing base pair substitutions, typically GC to AT transitions.
EMS is widely used in mutagenesis studies in various organisms, including plants and
microorganisms.

N-Nitroso-N-ethyl urea (ENU):

ENU is another alkylating agent that induces point mutations by alkylating DNA bases,
primarily ethylating guanine. It causes base pair substitutions, often GC to AT transitions,
similar to EMS. ENU is commonly used in genetic studies and mutagenesis screens in
animals, including mice, zebrafish, and Drosophila.

5-Bromouracil:

5-Bromouracil is a base analogue that resembles thymine and can pair with adenine or
guanine. It induces point mutations by causing base pair substitutions during DNA
replication. 5-Bromouracil is often used in experimental settings to study mutagenesis and
DNA repair processes.

Ethidium Bromide:

Ethidium bromide is an intercalating agent that inserts itself between DNA base pairs,
causing DNA distortion. It induces frameshift mutations by altering the spacing between
bases and disrupting the reading frame during DNA replication. Ethidium bromide is
commonly used in molecular biology laboratories for visualizing DNA in agarose gel
electrophoresis.

Nitrous Acid:
Nitrous acid is a deaminating agent that removes amino groups from DNA bases, particularly
adenine and cytosine. It induces point mutations by causing base pair substitutions, such as
GC to AT transitions due to deamination of cytosine to uracil. Nitrous acid has been used in
mutagenesis studies and in vitro DNA modification experiments.

Mitomycin C:

Mitomycin C is a crosslinking agent that forms covalent bonds between DNA strands,
inhibiting DNA replication and transcription. It induces various types of DNA damage,
including interstrand crosslinks and DNA-protein crosslinks. Mitomycin C is used in cancer
chemotherapy and as a research tool to induce DNA damage and study DNA repair
mechanisms.

These examples illustrate the diverse mechanisms by which chemical mutagens can induce
mutations in DNA, leading to genetic variability and providing insights into the fundamental
processes of genetics and molecular biology.

EFFECTS OF EMS ON MEDICINAL PLANTS

Ethyl Methane Sulphonate (EMS) treatment has numerous effects on medicinal plants,
including genetic alterations and physiological and biochemical changes. EMS acts as a
mutagen, inducing mutations within the plant genome, resulting in increased genetic
diversity. This diversity can be used for targeted breeding programs, enabling the
development of new cultivars with improved medicinal properties, yield, or stress tolerance.
EMS-induced mutations also affect physiological and biochemical processes, leading to
variations in bioactive compounds and altered medicinal properties. EMS-mediated
mutagenesis can confer tolerance to abiotic and biotic stresses, enhancing resilience and
resistance to pests, pathogens, or herbivores. This holds significant promise for advancing
healthcare, promoting agricultural sustainability, and addressing global health challenges.

1. Morphological Changes

Ethyl Methane Sulphonate (EMS) is a chemical that can cause significant morphological
changes in medicinal plants due to genetic mutations. These changes can affect growth
habits, flowering patterns, and leaf morphology. Growth habits may be influenced by genes
involved in hormone signalling, cell proliferation, or developmental processes. Flowering
patterns may change, with mutants displaying changes in time, size, colour, or arrangement.
Leaf morphology can also be affected. These morphological changes can be used as
phenotypic markers to identify mutants with desired traits, providing insights into the
functional consequences of mutagenesis in medicinal plants. Breeders can use these traits to
enhance medicinal properties, yield, and resilience in cultivated varieties.

2. Physiological Alterations

EMS-induced physiological changes in medicinal plants are crucial for their performance and
characteristics, influenced by biochemical and metabolic changes. These changes can lead to
variations in phytochemical composition and concentration, resulting in enhanced therapeutic
efficacy, increased antioxidant activity, or novel pharmacological activities. EMS-mediated
mutagenesis can also impact physiological processes related to stress responses and
environmental adaptation, such as altered responses to abiotic stresses and enhanced
resistance to biotic stresses. These alterations can also influence growth, development, and
resource allocation in medicinal plants, affecting overall performance, yield potential, and
adaptation to specific environmental conditions. Understanding these physiological changes
can help researchers identify promising mutants for further characterization and breeding
efforts to enhance medicinal properties, stress resilience, and productivity in cultivated
varieties.

3. Biochemical Changes

Ethyl Methane Sulphonate (EMS) treatment can significantly alter the biochemical properties
and physiological responses of medicinal plants. This includes changes in the synthesis,
accumulation, and distribution of biomolecules, affecting the medicinal properties and
physiological responses. EMS-induced mutations can modulate the expression of genes
involved in secondary metabolism pathways, leading to variations in the production of
phytochemicals like alkaloids, flavonoids, terpenoids, and phenolic compounds. These
changes can enhance therapeutic potency, antioxidant activity, or pharmacological effects.
EMS-mediated mutagenesis can also impact primary metabolic pathways, affecting plant
growth, development, and resource allocation. EMS treatment may also trigger changes in
enzymatic activities and biochemical processes associated with stress responses and
environmental adaptation. Mutants may exhibit alterations in antioxidant enzyme activities,
osmolyte accumulation, or hormone signalling pathways, enabling enhanced tolerance to
abiotic stresses. Understanding these biochemical alterations can help researchers identify
promising mutants for targeted breeding and cultivation strategies to enhance medicinal
properties, stress resilience, and overall productivity in cultivated varieties.

4. Molecular Changes
Ethyl Methane Sulphonate (EMS) treatment alters the genetic makeup and pathways of
medicinal plants, affecting gene expression, protein function, and regulatory networks. EMS
alkylates DNA bases, disrupting normal base pairing during DNA replication. This results in
mutations that alter the nucleotide sequence and potentially affect gene function. EMS-treated
plants may have genetic variants with novel phenotypic traits, such as changes in growth
habits, flowering patterns, or biochemical composition. EMS-mediated mutagenesis can
affect gene expression patterns, metabolic pathways, stress responses, and developmental
programs. These changes enable plants to withstand abiotic stresses like drought, salinity, or
temperature extremes, as well as biotic stresses like pests, pathogens, or herbivores.
Understanding these molecular mechanisms can help researchers identify promising mutants
for targeted breeding and cultivation strategies.

APPLICATIONS OF EMS IN MEDICINAL PLANT BREEDING

Ethyl Methane Sulphonate (EMS) is a valuable tool in medicinal plant breeding, allowing for
the induction of genetic variations and enhancement of desirable traits in cultivated varieties.
EMS treatment introduces point mutations, deletions, and insertions in the plant genome,
expanding the genetic pool for breeding programs aimed at improving medicinal properties,
yield, and stress tolerance. Breeders can create mutant germplasm banks, which serve as
valuable genetic resources for systematic screening and selection of individuals with desired
characteristics. EMS treatment also facilitates targeted improvement of medicinal properties
by inducing mutations in genes involved in secondary metabolism pathways, leading to
variations in efficacy, bioavailability, or pharmacological activities. Breeders can selectively
breed mutants with enhanced levels of specific phytochemicals or altered medicinal
properties, developing cultivars optimized for therapeutic or pharmaceutical purposes.

1. Enhancement of Medicinal Properties

Ethyl Methane Sulphonate (EMS) treatment is a method used to enhance the medicinal
properties of cultivated medicinal plants. It involves inducing mutations in genes involved in
secondary metabolism pathways, leading to significant changes in the biosynthesis and
accumulation of bioactive compounds within the plants. This allows breeders to develop
cultivars with enhanced medicinal properties tailored to specific therapeutic applications. One
notable outcome of EMS treatment is the augmentation of bioactive compound levels within
medicinal plants. Breeders can selectively breed mutants with elevated concentrations of
desired phytochemicals, such as alkaloids, flavonoids, or terpenoids, which can enhance the
therapeutic efficacy and potency of medicinal plant extracts. These bioactive compounds play
a crucial role in the pharmacological activities of medicinal plants, including antioxidant,
anti-inflammatory, antimicrobial, and anticancer effects. EMS-induced mutations can also
lead to the synthesis of novel bioactive compounds or the enhancement of existing
compounds with unique pharmacological properties. This precision breeding approach allows
for the development of cultivars tailored to meet diverse healthcare applications, from
traditional medicine to modern pharmaceutical formulations. EMS-based approaches hold the
potential to revolutionize the development of next-generation medicinal plant cultivars with
enhanced therapeutic efficacy, contributing to advancements in the healthcare and
pharmaceutical industries.

2. Improvement of Agronomic Traits

Ethyl Methane Sulphonate (EMS) treatment is a promising method for improving agronomic
traits in cultivated medicinal plants. By inducing mutations, breeders can generate genetic
diversity, enabling them to select variants with enhanced agronomic performance tailored to
specific cultivation environments and management practices. This leads to the enhancement
of yield-related traits, such as faster growth rates, higher branching density, or extended
flowering periods, which contribute to greater yields and more efficient cultivation practices.
EMS treatment can also lead to alterations in growth habits and plant architecture,
influencing agronomic characteristics such as plant height, canopy structure, and root
morphology. Mutants with modified growth habits may offer advantages in resource
utilization efficiency, nutrient uptake, or resistance to lodging, pests, and diseases, enhancing
their suitability for cultivation under diverse agroecological conditions. EMS-induced
mutations may confer tolerance to abiotic stresses, enhancing the resilience of medicinal
plants to adverse environmental conditions. Mutants with improved stress tolerance can
withstand challenging growing conditions, maintain productivity under suboptimal
circumstances, and reduce the need for inputs like irrigation, fertilizers, or pesticides,
promoting sustainable agriculture and resource conservation. EMS-mediated mutagenesis
also enables the development of cultivars with optimized flowering and fruiting
characteristics, facilitating more efficient harvests and post-harvest processing. This approach
holds immense promise for the development of cultivars tailored to meet the evolving needs
of growers, consumers, and the broader agricultural sector.

3. Development of Novel Cultivars

Ethyl Methane Sulphonate (EMS) treatment is a method used in medicinal plant breeding to
create novel cultivars. By inducing targeted mutations in the plant genome, EMS allows
breeders to generate genetic variations and explore uncharted territories of phenotypic
diversity. This approach enables the creation of cultivars with unique combinations of traits
tailored to specific agricultural, pharmaceutical, or market demands. EMS-mediated
mutagenesis introduces novel genetic variations that may not be readily available in the
natural gene pool of cultivated medicinal plants. Breeders can unlock hidden genetic potential
and discover novel traits or phenotypes with desired characteristics, laying the foundation for
the development of cultivars with enhanced medicinal properties, improved agronomic traits,
or superior stress resilience. EMS treatment facilitates targeted breeding efforts aimed at
addressing specific challenges or opportunities in medicinal plant cultivation. Breeders can
selectively screen mutant populations for variants exhibiting traits of interest, such as
increased yield, enhanced medicinal potency, or resistance to biotic and abiotic stresses.
Through rigorous phenotypic evaluation and molecular characterization, breeders can identify
and harness promising mutants for further breeding and cultivation, accelerating the
development of novel cultivars with superior performance and value.

CHALLENGES AND LIMITATIONS

1. Off-Target Mutations: EMS treatment may induce unintended mutations in the plant
genome, leading to undesirable phenotypic traits or genetic abnormalities that could
compromise the quality or performance of cultivated varieties.

2. Genetic Instability: Mutations induced by EMS may exhibit genetic instability, resulting
in phenotypic variability or loss of desired traits over successive generations, thereby
necessitating continuous selection and stabilization efforts.

3. Dosage Optimization: Determining the optimal EMS dosage for mutagenesis requires
careful consideration, as higher concentrations may increase mutagenicity but also elevate the
risk of inducing lethality or deleterious mutations, while lower concentrations may yield
insufficient mutagenic effects.

4. Labor-Intensive Screening: Identifying desirable mutants from large EMS-treated

populations necessitates labour-intensive phenotypic screening and molecular
characterization, which can be time-consuming, resource-intensive, and technically
challenging.

5. Limited Phenotypic Variation: Despite the introduction of genetic diversity, EMS

mutagenesis may yield limited phenotypic variation, particularly in traits controlled by
complex genetic networks or influenced by environmental factors, constraining the scope of
trait improvement.

6. Regulatory Compliance: Compliance with regulatory requirements governing the use of

mutagenic agents in plant breeding, including safety assessments, environmental impact
assessments, and regulatory approvals, may pose logistical and administrative challenges.
7. Limited Predictability: The outcomes of EMS-mediated mutagenesis may exhibit limited
predictability due to the stochastic nature of mutation induction and the complex interactions
between genetic, physiological, and environmental factors, necessitating iterative
experimentation and validation.

8. Integration with Breeding Programs: Integrating EMS mutagenesis with conventional

breeding techniques, such as marker-assisted selection or genome editing, requires careful
coordination and optimization to maximize the efficiency and efficacy of trait improvement
efforts.

FUTURE PERSPECTIVES

Ethyl Methane Sulphonate (EMS)-mediated mutagenesis in medicinal plant breeding holds

great potential for innovation, refinement, and integration with emerging technologies. By
understanding the molecular mechanisms underlying EMS-induced mutagenesis, researchers
can gain insights into the molecular basis of trait variation and develop strategies to enhance
efficiency and precision. Integrating EMS mutagenesis with advanced breeding techniques
like marker-assisted selection (MAS) and genome editing offers opportunities for
accelerating trait improvement in medicinal plants. This enables breeders to precisely target
and manipulate genes of interest, facilitating the rapid introgression of desirable traits into
elite cultivars. High-throughput phenotyping, genotyping, and omics technologies will
revolutionize the screening and characterization of EMS-treated populations. By harnessing
next-generation sequencing, transcriptomics, metabolomics, and phenomics, researchers can
systematically interrogate the genetic and molecular basis of trait variation, identify candidate
genes underlying desirable phenotypes, and elucidate complex interactions between genotype
and phenotype. The continued exploration of natural genetic variation and wild germplasm
resources holds immense potential for expanding the genetic diversity available for breeding
purposes. By tapping into the rich reservoir of genetic variability present in wild and landrace
populations, breeders can discover novel alleles, trait variations, and adaptive mechanisms
that can be harnessed to develop resilient, high-performing cultivars with enhanced medicinal
properties. The future of EMS-mediated mutagenesis in medicinal plant breeding is
characterized by innovation, integration, and collaboration across disciplines. By leveraging
advances in molecular biology, breeding technologies, and omics sciences, researchers can
unlock the full potential of EMS mutagenesis for accelerating trait improvement, enhancing
medicinal properties, and addressing global health challenges.

Optimization of EMS Treatment

Ethyl Methane Sulphonate (EMS) treatment protocols are essential for maximizing
mutagenesis efficiency and minimizing adverse effects on plant viability and genetic stability.
The process involves determining the appropriate concentration and duration of EMS,
targeting specific developmental stages to maximize DNA replication and repair processes.
Post-treatment procedures, such as rinsing, neutralization, and recovery treatments, help
mitigate EMS's cytotoxic effects and promote plant survival and regeneration. Quality control
measures, such as cytological analysis, phenotypic screening, and molecular characterization,
assess mutagenesis efficiency, verify desired mutations, and monitor genetic stability in
EMS-treated populations. By systematically evaluating and refining EMS mutagenesis
protocols, breeders can enhance efficiency, minimize adverse effects, and accelerate the
development of novel cultivars for medicinal plant breeding and crop improvement programs.

Integration with Modern Breeding Techniques

Ethyl Methane Sulphonate (EMS) mutagenesis is a promising method for improving traits
and cultivars in medicinal plants. It involves combining EMS mutagenesis with marker-
assisted selection (MAS) to screen large mutant populations, identify beneficial mutations,
and select desired phenotypes with greater precision. Genome editing technologies like
CRISPR-Cas9 allow breeders to target and modify specific genes underlying desired traits,
bypassing extensive phenotypic screening and selection. High-throughput phenotyping and
genotyping platforms help breeders systematically interrogate genetic and phenotypic
diversity generated through mutagenesis and identify novel variants with desired traits.
Advanced omics technologies, such as next-generation sequencing, transcriptomics,
metabolomics, and phenomics, can characterize the molecular basis of trait variation and
elucidate complex trait genetic architecture. Participatory breeding approaches, farmer
participatory research, and citizen science initiatives foster collaboration, knowledge sharing,
and technology adoption among diverse stakeholders in the medicinal plant community.

Exploration of Underutilized Medicinal Plants

Underutilized medicinal plants offer a promising way to expand genetic diversity, therapeutic
potential, and sustainable utilization of medicinal plant resources. These plants contain
valuable genetic resources, unique phytochemical profiles, and traditional knowledge systems
that can address unmet healthcare needs, promote agricultural diversity, and support rural
livelihoods. Researchers can preserve genetic diversity, maintain traditional knowledge, and
provide a foundation for future research, breeding, and cultivation efforts. Exploring
underutilized medicinal plants can uncover novel bioactive compounds, pharmacological
activities, and therapeutic properties with potential applications in healthcare and
pharmaceutical industries. By screening underutilized plant species for bioactivity,
researchers can identify promising candidates for drug discovery, pharmacological research,
and the development of new herbal medicines. The exploration of underutilized medicinal
plants also contributes to the revitalization of traditional medicine systems, indigenous
healing practices, and cultural heritage. By diversifying agricultural production, promoting
sustainable wild harvesting, and developing value-added products, stakeholders can create
new income streams, enhance food security, and promote rural development while supporting
biodiversity conservation and traditional knowledge systems.

REFERENCES
1. Aisyah, S. I., Yudha, Y. S., Sukma, D., & Nurcholis, W. (2022). PHENOTYPIC
VARIATION AND THE POLYPHENOLS CONTENT ALTERATION OF CELOSIA
CRISTATA DUE TO CHRONICALLY INDUCED MUTATION USING ETHYL
METHANE SULPHONATE. Journal of Southwest Jiaotong University, 57(3), 221–230.
https://doi.org/10.35741/issn.0258-2724.57.3.18

2. Altindal, D., & Altindal, N. (2018). Ayçiçeğinin (Helianthus annuus L. cv. Palancı-I) In
Vitro Tuzlu Koşullarda Gelişimi Üzerine Etil Metansülfonat (EMS) Uygulamalarının Etkisi.
Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 8(4), 351–359.
https://doi.org/10.21597/jist.432102

3. Ashrafi Parchin, R., Nasrollahnezhad Ghomi, A. A., Naghdi Badi, H., Navabpour, S.,
Mehrafarin, A., & Eskandari, A. (2021). Investigation effect of ethyl methane sulfonate
(EMS) on some of the morphophysiological and phytochemical traits of fenugreek
(Trigonella foenum-graecum L.). Industrial Crops and Products, 162, 113239.
https://doi.org/10.1016/j.indcrop.2021.113239

4. Chaudhari, A. K., Verma, S., & Chaudhary, B. R. (2015). Ethyl Methanesulphonate and
Sodium Azide Effects on Seedling Growth and Chlorophyll Mutations in Psoralea corylifolia
IC 111228. Journal of Crop Improvement, 29(5), 602–618.
https://doi.org/10.1080/15427528.2015.1070391

5. The Analysis of Morphological Diversity and Polyphenols Content of Celosia cristata in

M2 Population Induced by Ethyl Methane Sulphonate. Journal of Tropical Life Science,
13(1), 115–122. https://doi.org/10.11594/jtls.13.01.11

6. Dhakshanamoorthy, D., Selvaraj, R., & Chidambaram, A. (2013). Induced mutagenesis in

Jatropha curcas L. using ethyl methanesulphonate (EMS) and assessment of DNA
polymorphism through RAPD markers. Journal of Crop Science and Biotechnology, 16(3),
201–207. https://doi.org/10.1007/s12892-012-0079-x
7. Gerami, M. (2017). EFFECTS OF ETHYL METHANESULFONATE ON
MORPHOLOGICAL AND PHYSIOLOGICAL TRAITS OF PLANTS REGENERATED
FROM STEVIA (STEVIA REBAUDIANA BERTONI) CALLI. Applied Ecology and
Environmental Research, 15(3), 373–385. https://doi.org/10.15666/aeer/1503_373385

8. Ghosh, S., Ganga, M., & Soorianathasundaram, K. (2019). Studies on Mutagenic

Effectiveness and Efficiency of Gamma Rays and Ethyl Methane Sulphonate in Jasmine.
Current Journal of Applied Science and Technology, 1–8.
https://doi.org/10.9734/cjast/2019/v38i630414

9. Junaid, A., Mujib, A., & Sharma, M. P. (2008). Effect of growth regulators and
ethylmethane sulphonate on growth, and chlorophyll, sugar and proline contents in Dracaena
sanderiana cultured in vitro. Biologia Plantarum, 52(3), 569–572.
https://doi.org/10.1007/s10535-008-0113-5

10. Kiani, S., Kahrizi, D., Varmira, K., & Kassaee, S. M. (2022). The Effect of Ethyl
Methylsulfonate on Germination and Morphological Traits of Camelina as a Medicinal Plant.
Journal of Medicinal Plants and By-Product, Online First.
https://doi.org/10.22092/jmpb.2022.355966.1398

11. Kumar, M., Kumar, M., Prakash, S., Gautam, D., & Rao, S. (2016). Effect of seed
treatment by ethyl methane sulphonate on growth, flowering and yield of papaya cv. Pusa
Dwarf. Journal of Hill Agriculture, 7(1), 64. https://doi.org/10.5958/2230-7338.2016.00012.4

12. Kumar, S. P., & Kumari, B. D. R. (2021). Impact of Ethyl Methane Sulphonate
Mutagenesis in Artemisia vulgaris L. under NaCl Stress. BioTech, 10(3), 18.
https://doi.org/10.3390/biotech10030018

13. Lavanya, V., Ganga, M., Rajamani, K., Meenakumari, B., & Gnanam, R. (2022). The
efficiency of gamma irradiation and ethyl methane sulphonate in inducing variations in
Jasminum auriculatum Vahl. Journal of Applied and Natural Science, 14(4), 1163–1168.
https://doi.org/10.31018/jans.v14i4.3761

14. Lenawaty, D. Y., Sukma, D., Syukur, M., Suprapta, D. N., Nurcholis, W., & Aisyah, S. I.
(2022). Increasing the diversity of marigold (Tagetes sp.) by acute and chronic chemical-
induced mutation of EMS (Ethyl Methane Sulfonate). Biodiversitas Journal of Biological
Diversity, 23(3). https://doi.org/10.13057/biodiv/d230326

15. Purente, N., Chen, B., Liu, X., Zhou, Y., & He, M. (2020). Effect of Ethyl
Methanesulfonate on Induced Morphological Variation in M3 Generation of Chrysanthemum
indicum var. Aromaticum. HortScience, 55(7), 1099–1104.
https://doi.org/10.21273/HORTSCI15068-20
16. Uysal, H., Kızılet, H., Ayar, A., & Taheri, A. (2015). The use of an endemic Iranian plant,
Echium amoenum, against the ethyl methanesulfonate and the recovery of mutagenic effects.
Toxicology and Industrial Health, 31(1), 44–51. https://doi.org/10.1177/0748233712468019